Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort.
Suárez-García I, Ruiz-Algueró M, Alejos B, García-Yubero C, Belza MJ, Espacio R, Hernández J, Muñoz Sánchez J, Garaialde A, Alonso Socas MDM, Alcaraz A, Pierola Ruiz de Galarreta B, Martínez Madrid OJ, Gutiérrez Cuéllar I, Gómez-Ayerbe C, Olalla J, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Acquir Immune Defic Syndr. 2022 May 1;90(1):62-68. doi: 10.1097/QAI.0000000000002923. J Acquir Immune Defic Syndr. 2022. PMID: 35090156
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study.
Suárez-García I, Moreno C, Ruiz-Algueró M, Pérez-Elías MJ, Navarro M, Díez Martínez M, Viciana P, Pérez-Martínez L, Górgolas M, Amador C, de Zárraga MA, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. AIDS Res Ther. 2020 Jul 20;17(1):45. doi: 10.1186/s12981-020-00302-2. AIDS Res Ther. 2020. PMID: 32690099 Free PMC article.
HIV medical care interruption among people living with HIV in Spain, 2004-2020.
Izquierdo R, Rava M, Moreno-García E, Blanco JR, Asensi V, Cervero M, Curran A, Rubio R, Iribarren JA, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Izquierdo R, et al. AIDS. 2023 Jul 1;37(8):1277-1284. doi: 10.1097/QAD.0000000000003552. Epub 2023 Mar 21. AIDS. 2023. PMID: 36939068
Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.
Suárez-García I, Ruiz-Algueró M, García Yubero C, Moreno C, Belza MJ, Estébanez M, de Los Santos I, Masiá M, Samperiz Abad G, Muñoz Sánchez J, Omar M, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2020 Feb 1;75(2):466-472. doi: 10.1093/jac/dkz439. J Antimicrob Chemother. 2020. PMID: 31665404
Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.
Rava M, Domínguez-Domínguez L, Bisbal O, López-Cortés LF, Busca C, Antela A, González-Ruano P, Hernández C, Iribarren JA, Rubio R, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Rava M, et al. PLoS One. 2021 Apr 21;16(4):e0249864. doi: 10.1371/journal.pone.0249864. eCollection 2021. PLoS One. 2021. PMID: 33882093 Free PMC article.
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
Ruiz-Algueró M, Izquierdo R, Suárez-García I, Moreno C, Alejos B, Rava M, Moreno S, Montero Alonso M, Gutiérrez F, Gutierrez Cuellar I, Curran A, Hernando V, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Ruiz-Algueró M, et al. HIV Med. 2023 Jun;24(6):727-737. doi: 10.1111/hiv.13469. Epub 2023 Feb 21. HIV Med. 2023. PMID: 36810955
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in a multicentre cohort in Spain.
Suárez-García I, Alejos B, Ruiz-Algueró M, García Yubero C, Moreno C, Bernal E, Pérez-Is L, Zubero Z, de Zárraga Fernández MA, Samperiz Abad G, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Int AIDS Soc. 2021 Jul;24(7):e25758. doi: 10.1002/jia2.25758. J Int AIDS Soc. 2021. PMID: 34291580 Free PMC article.
11 results